BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26339947)

  • 21. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma in Hong Kong Chinese patients.
    Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
    Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
    Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
    Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micromedullary thyroid cancer: how micro is truly micro?
    Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
    Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medullary thyroid cancer: surgical results and prognostic factors].
    Dequanter D; Lothaire P
    Rev Med Liege; 2010; 65(7-8):450-2. PubMed ID: 20857703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
    Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.
    Grozinsky-Glasberg S; Benbassat CA; Tsvetov G; Feinmesser R; Peretz H; Shimon I; Lapidot M
    Thyroid; 2007 Jun; 17(6):549-56. PubMed ID: 17614776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of reoperations for medullary thyroid carcinoma.
    Fialkowski E; DeBenedetti M; Moley J
    World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
    Randle RW; Bates MF; Schneider DF; Sippel RS; Pitt SC
    J Surg Oncol; 2018 May; 117(6):1211-1216. PubMed ID: 29266278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 35. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
    Gimm O; Ukkat J; Dralle H
    World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
    Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.